• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立药效团模型和VolSurf模型以预测尿苷二磷酸葡萄糖醛酸基转移酶1A3的底物。

Establishment of pharmacophore and VolSurf models to predict the substrates of UDP-glucuronosyltransferase1A3.

作者信息

Wu Zhufeng, Zhang Xingwang, Ma Zhiguo, Wu Baojian

机构信息

Division of Pharmaceutics, College of Pharmacy, Jinan University , Guangzhou , China.

出版信息

Xenobiotica. 2015;45(8):653-62. doi: 10.3109/00498254.2015.1016136. Epub 2015 Apr 2.

DOI:10.3109/00498254.2015.1016136
PMID:25837689
Abstract

1.UDP-glucuronosyltransferase1A3 (UGT1A3) catalyzes glucuronidation of numerous xenobiotics/drugs. Here, we aimed to establish substrate selectivity models for UGT1A3 using the pharmacophore and VolSurf approaches. 2.Fifty structurally diverse substrates of UGT1A3 were collated from the literature. These substrates were divided into training (n=34) and test sets (n=16). The pharmacophore model was developed using the Discovery Studio 2.5 software. A user-defined feature (i.e. the glucuronidation site) was included in the program for model generation. The VolSurf model was derived using the VolSurf program implemented in SYBYL 8.0 software. 3.The pharmacophore model consisted of three features (i.e. one glucuronidation site and two hydrogen-bond acceptors). The activities of 81% of test set substrates were adequately predicted (deviated by less than one-log unit) by the model, suggestive of a satisfactory predictive power. The refined VolSurf model based on 22 molecular descriptors was statistically significant (r(2)=0.793, q(2)=0.606). It also processed a good predictability as the activities of 14 test set compounds were well predicted. The VolSurf model highlighted the chemical features (including large molecule size, hydrophilic regions and hydrogen-bonding groups) contributing to favored glucuronidation by UGT1A3. 4.In conclusion, two predictive 3D-QSAR models (i.e. the pharmacophore and VolSurf models) for UGT1A3 were successfully established. These models contributed to an improved understanding of the substrate preference of UGT1A3 and a more comprehensive prediction of UGT-mediated metabolism.

摘要

1.尿苷二磷酸葡萄糖醛酸基转移酶1A3(UGT1A3)催化多种异生物素/药物的葡萄糖醛酸化反应。在此,我们旨在运用药效团和VolSurf方法建立UGT1A3的底物选择性模型。2.从文献中整理出50种结构各异的UGT1A3底物。这些底物被分为训练集(n = 34)和测试集(n = 16)。使用Discovery Studio 2.5软件开发药效团模型。在模型生成程序中纳入了一个用户定义特征(即葡萄糖醛酸化位点)。VolSurf模型是使用SYBYL 8.0软件中实现的VolSurf程序推导得出的。3.药效团模型由三个特征组成(即一个葡萄糖醛酸化位点和两个氢键受体)。该模型能够充分预测81%的测试集底物的活性(偏差小于一个对数单位),表明其具有令人满意的预测能力。基于22个分子描述符的优化VolSurf模型具有统计学意义(r(2)=0.793,q(2)=0.606)。由于14种测试集化合物的活性得到了良好预测,所以它也具有良好的预测性。VolSurf模型突出了有助于UGT1A3进行有利葡萄糖醛酸化反应的化学特征(包括大分子尺寸、亲水区和氢键基团)。4.总之,成功建立了两种用于UGT1A3的预测性三维定量构效关系模型(即药效团模型和VolSurf模型)。这些模型有助于更好地理解UGT1A3的底物偏好,并更全面地预测UGT介导的代谢过程。

相似文献

1
Establishment of pharmacophore and VolSurf models to predict the substrates of UDP-glucuronosyltransferase1A3.建立药效团模型和VolSurf模型以预测尿苷二磷酸葡萄糖醛酸基转移酶1A3的底物。
Xenobiotica. 2015;45(8):653-62. doi: 10.3109/00498254.2015.1016136. Epub 2015 Apr 2.
2
3D-QSAR studies on UDP-glucuronosyltransferase 2B7 substrates using the pharmacophore and VolSurf approaches.使用药效团和VolSurf方法对UDP-葡萄糖醛酸基转移酶2B7底物进行的3D-QSAR研究。
Xenobiotica. 2012 Sep;42(9):891-900. doi: 10.3109/00498254.2012.675094. Epub 2012 Apr 12.
3
In silico modeling of UDP-glucuronosyltransferase 1A10 substrates using the VolSurf approach.使用 VolSurf 方法对 UDP-葡糖醛酸基转移酶 1A10 底物进行计算机建模。
J Pharm Sci. 2012 Sep;101(9):3531-9. doi: 10.1002/jps.23100. Epub 2012 Mar 2.
4
Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates.尿苷二磷酸葡萄糖醛酸基转移酶1A1(UGT1A1)底物的药效团及定量构效关系建模
Pharmacogenetics. 2002 Nov;12(8):635-45. doi: 10.1097/00008571-200211000-00008.
5
Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity.药效团与定量构效关系建模:用于合理化和预测UDP-葡萄糖醛酸基转移酶1A4底物选择性的互补方法。
J Med Chem. 2003 Apr 24;46(9):1617-26. doi: 10.1021/jm020397c.
6
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.人源UDP-葡萄糖醛酸基转移酶1A3催化的胺类及其他外源性物质的葡萄糖醛酸化反应
Drug Metab Dispos. 1998 Jun;26(6):507-12.
7
Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity.用于研究人尿苷二磷酸葡萄糖醛酸转移酶同工型底物选择性的多种药效基团。
Mol Pharmacol. 2004 Feb;65(2):301-8. doi: 10.1124/mol.65.2.301.
8
Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.通过定量构效关系建模和同源酶分析理解人类尿苷二磷酸葡萄糖醛酸转移酶的底物选择性
Xenobiotica. 2012 Aug;42(8):808-20. doi: 10.3109/00498254.2012.663515. Epub 2012 Mar 2.
9
In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.基于 4D-指纹和 MOE 描述符的 hERG 阻断虚拟二进制分类 QSAR 模型预测。
J Chem Inf Model. 2010 Jul 26;50(7):1304-18. doi: 10.1021/ci100081j.
10
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.预测人体药物葡萄糖醛酸化参数:用于反应表型分析的 UDP-葡萄糖醛酸基转移酶酶选择性底物和抑制剂探针,以及用于预测药物清除率和药物相互作用潜力的体外-体内外推。
Drug Metab Rev. 2010 Feb;42(1):196-208. doi: 10.3109/03602530903210716.